2017-11-15 SGB Conference Call

From HL7Wiki
Jump to navigation Jump to search

back to Standards Governance Board main page

HL7 SGB Minutes

Location:
https://global.gotomeeting.com/join/538465637

Date: 2017-11-15
Time: 10:00 AM Eastern
Facilitator Paul/Calvin Note taker(s) Anne
Attendee Name


x Calvin Beebe
x Lorraine Constable
x Russ Hamm
Regrets Tony Julian
x Paul Knapp
x Austin Kreisler
Wayne Kubick
Thom Kuhn
Ken McCaslin
Rik Smithies
Sandy Stuart
Quorum: Chair + 4

Agenda

  • Agenda review
  • Approve Minutes of 2017-11-08_SGB_Conference_Call
  • Action Items
    • Review GOM with respect to where SGB and precepts should be reflected
    • Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
    • Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
  • Discussion Topics
    • Finish review of mixed ballot content precept
    • Precept implementation strategy
    • Backwards compatibility consistency and definition across families
    • Product families to develop an approach to indicating the maturity of the products
  • Precepts to Develop
  • Parking Lot
    • Review Publishing M&C updates regarding dual roles
    • How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
    • Review Mission and Charter
    • Handling situations where two documents come out of one project
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Drafting Shared Product Management Responsibilities
    • Levels of standards
    • Separation of concerns
    • Ownership of content
    • ISM
    • Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize

Minutes

  • Agenda review
    • Discussion re: next week's call.
    • Add finishing up Product Life Cycle document
  • Approve Minutes of 2017-11-08_SGB_Conference_Call
    • MOTION to approve: Calvin/Paul
    • VOTE: All in favor
  • Action Items
    • Review GOM with respect to where SGB and precepts should be reflected
      • ACTION: Move to parking lot
    • Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
      • ACTION: Remove from actions
    • Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
      • ACTION: Anne to email item to Paul
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
      • Carry forward to next week
  • Discussion Topics
    • Review TSC recommendations on Product Life Cycle document.
      • Narrowed groups affected to formalized product families. Will add more as they form. Edited the application of the precept section. Discussion over reviewing the BAM in light of this precept.
        • ACTION: Anne to add to TSC agenda
    • Finish review of mixed ballot content precept
      • Group reviews. Made minor edits.
        • ACTION: Review further on 2017-11-29 call
    • Precept implementation strategy
    • Backwards compatibility consistency and definition across families
    • Product families to develop an approach to indicating the maturity of the products
      • Remove
  • Precepts to Develop
  • Parking Lot
    • Review Publishing M&C updates regarding dual roles
    • How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
    • Review Mission and Charter
    • Handling situations where two documents come out of one project
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Drafting Shared Product Management Responsibilities
    • Levels of standards
    • Separation of concerns
    • Ownership of content
    • ISM
    • Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize


Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved